Publication Description
Time‐to‐event outcomes are common in clinical studies. For example, the time to a first major adverse cardiovascular event (MACE, defined as CVD death, nonfatal myocardial infarction, or stroke) is a commonly used outcome in cardiovascular outcome trials. Owing to the lengthy time frame and other factors, the high costs of conducting such studies has been identified as one of the major obstacles in conducting clinical trials in the United States. However, typical approaches for designing clinical trials with time‐to‐event outcomes do not consider study costs. For a given effect size (eg, hazard ratio), the power to detect differences between two groups is typically a function of the total number of events observed in the study. Therefore, the same level of power will be achieved based on various combinations of the total number of participants, length of enrollment and total follow‐up times, and group allocation probability. Herein, we provide a general framework for designing cost‐efficient studies comparing treatments with respect to continuous time‐to‐event outcomes. Among the various designs that achieve the desired level of power to detect a given effect size for a fixed type‐I error level, the optimal cost‐efficient design is the design that minimizes the expected total study cost. The method is general and can be used for Cox proportional hazards models or Aalen additive models, and under various recruitment and censoring assumptions. The proposed approach for designing cost‐efficient studies is illustrated for a Weibull time‐to‐event outcome with uniform recruitment and exponentially distributed censoring time. The case of an additive hazards model is also described. A Shiny web application implementation of the proposed methods is presented.